Because patients suffering from rare or neglected diseases are looking for solutions, we are committed to finding the best ones by building effective partnerships and developing new therapies. Our goal is to bring life to hope for patients all around the world.

Our products

Product Therapeutic area Status More information
Dexliq
Oncology, Hematology, immunology...
Marketed
EU 2018
Liquiband*
Wounds
Marketed
EU 2019
Miglustat*
Inherited metabolic disorder
Marketed
EU Jul 2018
Neofordex
Haematology
Marketed
EU MA Mar 2016
Orphacol
Digestive system diseases, metabolism, inborn errors
Marketed
EU MA Sept 2013
Siklos
Haematology
Marketed
EU Mai 2011

Theravia a mis en place une démarche d’amélioration continue par le biais d’une politique qualité.
L’ensemble du personnel theravia impliqué de façon directe ou indirecte dans l’information promotionnelle des médicaments s’est engagé à respecter la Charte de l’Information par Démarchage ou Prospection Visant à la Promotion du Médicament (Octobre 2014).

*As distibutor

Therapeutic areas

Read more

Our products

Read more

PV Informations

Read more

Contact

Contact theravia

Read more